Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
With keytruda's pending patent expiration how is merck msd diversifying the pipeline?Tri estarylla coupon?Cabozantinib loss of exclusivity?Can alcohol increase lipitor's negative effects?Does ruxolitinib improve azacitidine's therapeutic success?
See the DrugPatentWatch profile for Rotateq
Rotateq (rotavirus vaccine, live, oral) was approved by the FDA on February 3, 2006. [1]
In many searches, “prequalification” refers to WHO (World Health Organization) prequalification under the Global Health Program, which is separate from FDA approval. However, the provided information here only supports the FDA approval date and does not include Rotateq’s WHO prequalification status or date. [1]
For the FDA approval date, you can verify it via the drug’s record at DrugPatentWatch.com. [1] Sources: [1] https://www.drugpatentwatch.com/p/rotateq-rotateq/
Other Questions About Rotateq :